Nasdaq · Healthcare
DarioHealth Corp. (DRIO)
As-reported financials and recent SEC filings for DarioHealth Corp., latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.
Snapshot
Revenue
$22.4M
Net income
$-41.7M
Net margin
—
Diluted EPS
$10.12
ROE
-61.4%
P/E (TTM)
—
Market cap
—
Debt / equity
0.5×
Income statement (as reported)
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $22.4M | $27.0M | $20.4M | $27.7M | $20.5M |
| Gross profit | $12.7M | $13.3M | $6.0M | $9.7M | $4.0M |
| Operating income | $-36.7M | $-57.7M | $-56.2M | $-56.8M | $-76.5M |
| Net income | $-41.7M | $-42.7M | $-59.4M | $-62.2M | $-76.8M |
| Diluted EPS | $10.12 | $12.27 | $23.16 | $30.48 | $48.84 |
Source: company XBRL financial statements on SEC EDGAR.
Recent SEC filings
10-Q2026-05-13
View on EDGAR →SD2026-05-07
View on EDGAR →32026-04-13
View on EDGAR →8-K2026-04-13
View on EDGAR →8-K2026-03-30
View on EDGAR →424B52026-03-30
View on EDGAR →EFFECT2026-03-27
View on EDGAR →CORRESP2026-03-25
View on EDGAR →Largest Healthcare peers
Go deeper on DRIO
Search DarioHealth Corp.’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.
Start freeOr check your whole portfolio free — no account needed.
Data sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.